Immunization (CACDI)
The immunizing agent identified through its trade name or generic name
3: Ready for use
Additional details on an immunization product can be mapped through the National Vaccine Catalogue (NVC), such as the Global Trade Item Number (GTIN). GTINs are mapped to the vaccine lot and tradename using the associated drug identification number (DIN), where available.
Recommended Terminologies
SNOMED CT CA where concept is a member of 22061000087108 | Administered tradename codes for vaccines reference set (foundation metadata concept) | or 22071000087104 | Historical name codes for vaccines reference set (foundation metadata concept) | or 22041000087107 | Administered tradename codes for passive immunizing agents reference set (foundation metadata concept) | or 22051000087105 | Historical name codes for passive immunizing agents reference set (foundation metadata concept) | or 787482006 | No known immunizations (situation) |
- [MMR] M-M-R II
- [Tdap] ADACEL
-
[Inf] FLULAVAL TETRA
-
[MMR] Measles, mumps and rubella vaccine
- [Tdap] Tetanus, diphtheria, and acellular pertussis adult vaccine
- [Inf] Influenza vaccine
3: Ready for use
Tradename immunizing agent will be used to document an immunization event when the administered or reported immunizing product is known by its marketed or brand name.
Generic immunizing agent will be used when the reported immunizing product is known by its generic or non-branded name, or when the specific trade name is not available or required.
Contact us
If you have questions about this initiative, would like to be added to our stakeholder notification list or would like to participate in our consultations, please email us.
How to cite:
Canadian Institute for Health Information. Immunization (CACDI). Accessed November 02, 2026.
